Charles Schwab’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-154,667
| Closed | -$1.4M | – | 3716 |
|
2024
Q1 | $1.4M | Buy |
154,667
+5,241
| +4% | +$47.4K | ﹤0.01% | 2696 |
|
2023
Q4 | $1.62M | Buy |
149,426
+10,497
| +8% | +$114K | ﹤0.01% | 2675 |
|
2023
Q3 | $1.12M | Buy |
138,929
+3,864
| +3% | +$31.1K | ﹤0.01% | 2761 |
|
2023
Q2 | $1.47M | Buy |
135,065
+115,496
| +590% | +$1.25M | ﹤0.01% | 2645 |
|
2023
Q1 | $135K | Sell |
19,569
-5,091
| -21% | -$35.1K | ﹤0.01% | 3212 |
|
2022
Q4 | $98.1K | Buy |
24,660
+11,851
| +93% | +$47.2K | ﹤0.01% | 3261 |
|
2022
Q3 | $86K | Hold |
12,809
| – | – | ﹤0.01% | 3237 |
|
2022
Q2 | $62K | Sell |
12,809
-82,238
| -87% | -$398K | ﹤0.01% | 3361 |
|
2022
Q1 | $889K | Buy |
95,047
+2,281
| +2% | +$21.3K | ﹤0.01% | 2902 |
|
2021
Q4 | $1.1M | Hold |
92,766
| – | – | ﹤0.01% | 2870 |
|
2021
Q3 | $1.06M | Buy |
92,766
+1,721
| +2% | +$19.6K | ﹤0.01% | 2857 |
|
2021
Q2 | $1.63M | Buy |
91,045
+16,213
| +22% | +$291K | ﹤0.01% | 2784 |
|
2021
Q1 | $1.16M | Buy |
74,832
+13,412
| +22% | +$208K | ﹤0.01% | 2809 |
|
2020
Q4 | $750K | Buy |
61,420
+3,954
| +7% | +$48.3K | ﹤0.01% | 2863 |
|
2020
Q3 | $739K | Buy |
57,466
+6,241
| +12% | +$80.3K | ﹤0.01% | 2760 |
|
2020
Q2 | $521K | Buy |
51,225
+2,060
| +4% | +$21K | ﹤0.01% | 2813 |
|
2020
Q1 | $400K | Buy |
49,165
+17,475
| +55% | +$142K | ﹤0.01% | 2789 |
|
2019
Q4 | $274K | Hold |
31,690
| – | – | ﹤0.01% | 2993 |
|
2019
Q3 | $196K | Hold |
31,690
| – | – | ﹤0.01% | 3041 |
|
2019
Q2 | $527K | Buy |
31,690
+7,815
| +33% | +$130K | ﹤0.01% | 2786 |
|
2019
Q1 | $400K | Buy |
23,875
+4,525
| +23% | +$75.8K | ﹤0.01% | 2841 |
|
2018
Q4 | $223K | Hold |
19,350
| – | – | ﹤0.01% | 3003 |
|
2018
Q3 | $774K | Buy |
19,350
+2,400
| +14% | +$96K | ﹤0.01% | 2701 |
|
2018
Q2 | $480K | Buy |
+16,950
| New | +$480K | ﹤0.01% | 2818 |
|